PFCS
Pale Fire Capital SE Portfolio holdings
AUM $958M
1-Year Return
80.1%
This Quarter Return
+37.32%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$958M
AUM Growth
+$128M
(+15%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-10.68%
Top 10 Holdings %
Top 10 Hldgs %
86.75%
Holding
75
New
13
Increased
24
Reduced
13
Closed
15
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
+$17.6M |
| 2 |
SPPP
Sprott Physical Platinum and Palladium Trust
SPPP
|
+$13.8M |
| 3 |
Match Group
MTCH
|
+$12.9M |
| 4 |
Angi Inc
ANGI
|
+$12.8M |
| 5 |
IAMGOLD
IAG
|
+$9.71M |
Top Sells
| 1 |
B
Barrick Mining Corporation
B
|
+$146M |
| 2 |
Coeur Mining
CDE
|
+$33.5M |
| 3 |
NGD
New Gold Inc
NGD
|
+$4.04M |
| 4 |
Uber
UBER
|
+$2.19M |
| 5 |
CIM
Chimera Investment
CIM
|
+$1.39M |
Sector Composition
| 1 | Materials | 41.11% |
| 2 | Communication Services | 40.33% |
| 3 | Consumer Staples | 9.09% |
| 4 | Healthcare | 5.77% |
| 5 | Energy | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
26
Chimera Investment
CIM
$1.15B
| $1.49M | 0.15% |
107,708
-99,912
| -48% | -$1.39M |
|
27
Liquidia Corp
LQDA
$2.3B
| $1.07M | 0.11% |
+85,700
| New | +$1.07M |
|
28
Caribou Biosciences
CRBU
$170M
| $977K | 0.1% |
775,055
-11,667
| -1% | -$14.7K |
|
|
CYBN
29
Cybin
CYBN
$142M
| $946K | 0.1% |
112,805
| – | – |
|
|
QIPT
30
Quipt Home Medical
QIPT
$116M
| $824K | 0.08% |
460,303
+213,807
| +87% | +$383K |
|
31
Adecoagro
AGRO
$813M
| $774K | 0.08% |
+84,637
| New | +$774K |
|
32
Adverum Biotechnologies
ADVM
$64.4M
| $771K | 0.08% |
358,724
-9,543
| -3% | -$20.5K |
|
33
Talos Energy
TALO
$1.66B
| $746K | 0.08% |
87,994
-15,242
| -15% | -$129K |
|
|
MITT
34
AG Mortgage Investment Trust
MITT
$248M
| $387K | 0.04% |
51,202
| – | – |
|
35
Perma-Fix Environmental Services
PESI
$162M
| $270K | 0.03% |
25,689
+15,609
| +155% | +$164K |
|
36
Harrow
HROW
$1.58B
| $265K | 0.03% |
8,683
+550
| +7% | +$16.8K |
|
37
89bio
ETNB
$1.19B
| $261K | 0.03% |
26,578
+1,800
| +7% | +$17.7K |
|
38
Lifecore Biomedical
LFCR
$287M
| $249K | 0.03% |
+30,686
| New | +$249K |
|
39
Journey Medical
DERM
$187M
| $233K | 0.02% |
32,458
+5,184
| +19% | +$37.2K |
|
40
Regenxbio
RGNX
$459M
| $229K | 0.02% |
27,846
+2,000
| +8% | +$16.4K |
|
41
Day One Biopharmaceuticals
DAWN
$735M
| $226K | 0.02% |
34,843
+3,150
| +10% | +$20.5K |
|
42
Rezolute
RZLT
$650M
| $219K | 0.02% |
49,122
+2,000
| +4% | +$8.92K |
|
43
scPharmaceuticals
SCPH
$301M
| $218K | 0.02% |
+57,128
| New | +$218K |
|
44
Arrowhead Research
ARWR
$3.96B
| $214K | 0.02% |
13,571
+1,350
| +11% | +$21.3K |
|
45
Celcuity
CELC
$2.34B
| $213K | 0.02% |
15,940
-1,700
| -10% | -$22.7K |
|
46
Noble Corp
NE
$4.85B
| $212K | 0.02% |
+8,000
| New | +$212K |
|
47
Ultragenyx Pharmaceutical
RARE
$2.79B
| $204K | 0.02% |
+5,600
| New | +$204K |
|
48
Nuvation Bio
NUVB
$1.08B
| $187K | 0.02% |
95,642
+50,000
| +110% | +$97.5K |
|
49
Immatics
IMTX
$693M
| $184K | 0.02% |
34,270
| – | – |
|
50
McEwen Inc.
MUX
$765M
| $119K | 0.01% |
+12,350
| New | +$119K |
|